Skip to main content

Table 3 Comparison of the intraoperative fluid management and the use of vasoactive drugs of both group

From: Goal-directed fluid therapy using stroke volume variation on length of stay and postoperative gastrointestinal function after major abdominal surgery-a randomized controlled trial

 

Control group

GDFT group

P value

Net amount infused, [ml, median (IQR)]

2750 (2250–3300)

1975 (1575–2600)

< 0.001*

Crystalloid, [ml, median (IQR)]

2200 (2025–2513)

1600 (837–2100)

< 0.001*

Colloid, [ml, median (IQR)]

500 (0–1000)

500 (500–1000)

0.981

Urine output, [ml, median (IQR)]

350 (200–800)

600 (300–800)

0.041*

Blood loss, [ml, median (IQR)]

100 (0–350)

100 (50–225)

0.970

Vasopressor or inotrope, n (%)

18 (36)

27 (54)

0.072

 Norepinephrine, n[mg, median (IQR)]

10 [0.04(0.02–0.10)]

13 [0.06(0.04–0.12)]

 Dobutamine, n[mg,median (IQR)]

2 [2.62(0–3.50)]

6 [2.55(0–3.50)]

 Phenylephrine, n[mg, median (IQR)]

6 [0.05(0.01–0.1)]

7 [0.04(0.02–0.05)]

 Ephedrine, n[mg,median (IQR)]

0

1 [6]

  1. Data are presented as median (IQR, interquartile ranges), or absolute numbers (n, % percentage)
  2. Data were compared using Mann–Whitney U-test, or Fisher’s exact test as appropriate
  3. *Statistical significance (P < 0.05) compared with control